Advanced Therapies Congress (London, Mar 19-20, 2024)

Abstract:

The Advanced Therapies Congress convenes leaders in cell and gene therapy development across diverse sectors: pharma, biotech, startups, researchers, clinicians, academics, HTAs, payers, and regulators. In 2024, our new Gene Editing Track highlights CRISPR and Zinc Finger Nucleases’ strides, probing their ethical implications, while the Immunotherapy Track showcases the latest in immune-oncology and collaborations in cancer treatment.

Our comprehensive agenda spans 8 tracks, delving into manufacturing, supply chain, pricing, and breakthroughs in pivotal areas like cell therapy, gene editing, and regenerative medicine. In a landscape of uncertainty, we unite biotech trailblazers, pharma innovators, startups, and solution providers to navigate the future of cell and gene therapy in our dynamic world.

Related services: